Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB OR BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN REAL LIFE CONDITIONS

NCT03073109 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03073109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03073109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB OR BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN REAL LIFE CONDITIONS
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 15, 2017
Completion date
September 16, 2019
Enrollment
170 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid